
Belvedere Trading’s BridgeBio Pharma BBIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-11,316
| Closed | -$311K | – | 208 |
|
2024
Q4 | $311K | Buy |
11,316
+1,905
| +20% | +$52.3K | ﹤0.01% | 89 |
|
2024
Q3 | $240K | Sell |
9,411
-243
| -3% | -$6.19K | ﹤0.01% | 87 |
|
2024
Q2 | $245K | Sell |
9,654
-5,323
| -36% | -$135K | ﹤0.01% | 82 |
|
2024
Q1 | $463K | Sell |
14,977
-12,094
| -45% | -$374K | ﹤0.01% | 40 |
|
2023
Q4 | $1.09M | Sell |
27,071
-2,658
| -9% | -$107K | ﹤0.01% | 22 |
|
2023
Q3 | $784K | Buy |
29,729
+16,050
| +117% | +$423K | ﹤0.01% | 24 |
|
2023
Q2 | $235K | Sell |
13,679
-18,910
| -58% | -$325K | ﹤0.01% | 56 |
|
2023
Q1 | $540K | Buy |
+32,589
| New | +$540K | ﹤0.01% | 33 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 117 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 145 |
|
2022
Q1 | – | Sell |
-7,660
| Closed | -$79K | – | 200 |
|
2021
Q4 | $79K | Buy |
+7,660
| New | +$79K | ﹤0.01% | 105 |
|